Why “Emulate” is being discussed
The most recent Hacker News stories and comments contributing to this topic's mentions.
Why do you people love over-engineering and bad architectures so much? Do you have any sense of engineering beauty? Modern CPUs already run every application in an isolated sand…
by codedokode · Oct 31, 2026
Even if they had bought all the books, wouldn’t people still be mad they trained an AI with it? I doubt it would quell the “It can emulate an Author’s style” complaints.
by 0x20cowboy · Oct 31, 2026
I think maybe a similar thing in Albania. Lots of people deep-down wanting to emulate the same power structures that oppress them. Cycles of abuse. The ones who don’t leave.
by randysalami · Oct 31, 2026
> I feel like this is... a bit too much, no? Particularly the cellular part. I see the appeal of staying off the grid, but people with families would certainly struggle with thi…
by embedding-shape · Oct 31, 2026
I made something like this about a year ago. It worked until it didn't. My assessment is that an individual bypass isn't that hard, but doing it at scale is an entirely differen…
by manofmanysmiles · Oct 31, 2026
That had to be painful. "You could just emulate the actual iPod firmware with a few thousand AI-generated lines of WebAssembly, but that would mean putting our firmware out in t…
by joezydeco · Oct 30, 2026
Interest
Proportion of Hacker News items mentioning "emulate" over time.
Mentions
Total number of Hacker News items mentioning "emulate" over time.
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting. This initiative is designed to provide clinicians with better data about how an individual patient may respond to treatment. The company also signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration to advance and qualify its Human Emulation System to meet regulatory evaluation for product testing. Read more on Wikipedia